![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Shuvo Roy | |
---|---|
Born | |
Citizenship | United States |
Alma mater | Mount Union College Case Western Reserve University |
Known for | Co-invention of an implantable artificial kidney, medical MEMS |
Scientific career | |
Fields | Bioengineering, Biomedical MEMS, Pediatric Devices |
Institutions | University of California, San Francisco |
Doctoral advisor | Mehran Mehregany |
Shuvo Roy is an American biomedical engineering known for his work with Bio-MEMS including the invention of an artificial kidney. [1] He currently serves as a professor at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco.
Shuvo Roy was born on 10 November 1969 in Dhaka (now in Bangladesh) to Ashok Nath Roy, a public health physician, and Ratna Roy, a teacher. His grandfather Nagen Dey was a professor of English at Sir Ashutosh Mukherjee College, Boalkhali. He hails from Chittagong Division, his paternal family being from Rosangiri in Fatikchhari and his maternal family being from Alkaran Ward. [2]
Roy started his elementary education in Siddheswari in Dhaka but moved with his father, mother and siblings to Uganda in 1974 where he received most of his education including at the Jinja Senior Secondary School (his mother being employed at the institution). [1]
The family later moved to the US where Roy completed his education and earned his BS degree from University of Mount Union, Ohio in 1992. He then earned his MS degree in Electrical Engineering and Applied Physics from Case Western Reserve University in 1995. He went on to earn his PhD degree from the same school in 2001. [3]
Roy also spent a part of his childhood in India where most of his paternal family has settled (while his maternal family still resides in Bangladesh) and has been described as an Indian American. [1]
He married Monica Matthews, an American, around 2003. [2] He has two siblings: Joy Roy, a vascular surgeon, and Chaiti Roy, an anesthetic. [2]
Roy has developed silicon nanopore membranes (SNM) to achieve high-efficiency blood ultrafiltration while selectively retaining specific solutes and serving as an immunoprotective barrier for encapsulated cells. The SNM are the fundamental underlying technology for the development of an implantable bioartificial kidney. [4]
Using this technology, he has shown feasibility for an implantable bioartificial pancreas (iBAP). Previous attempts to develop a bioartificial pancreas have been severely limited by insufficient mass transfer and a limited supply of beta cells, but Roy says that ultra-high hydraulic permeability characteristic of the SNM will enable appropriate mass transport (especially oxygen, glucose, and insulin) to achieve optimal beta cell performance, while the ultra-selective pore characteristic of the SNM enable unprecedented immunoisolation. Also the iBAP can utilize a human stem cell derived fully functional beta cell that provides and unlimited supply of beta cells. [5]
He is a founding member of the University of California, San Francisco Pediatric Device Consortium. [3]
![]() |
Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.
An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. The replaced function does not have to be related to life support, but it often is. For example, replacement bones and joints, such as those found in hip replacements, could also be considered artificial organs.
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can is considered as a field of its own.
Artificial kidney is often a synonym for hemodialyzer, but may also refer to the other renal replacement therapies that are in use and/or in development. This article deals mainly with bio-artificial kidneys featuring cells that are grown from renal cell lines/renal tissue.
Rahul Sarpeshkar is the Thomas E. Kurtz Professor and a professor of engineering, professor of physics, professor of microbiology & immunology, and professor of molecular and systems biology at Dartmouth. Sarpeshkar, whose interdisciplinary work is in bioengineering, electrical engineering, quantum physics, and biophysics, is the inaugural chair of the William H. Neukom cluster of computational science, which focuses on analog, quantum, and biological computation. The clusters, designed by faculty from across the institution to address major global challenges, are part of President Philip Hanlon's vision for strengthening academic excellence at Dartmouth. Prior to Dartmouth, Sarpeshkar was a tenured professor at the Massachusetts Institute of Technology and led the Analog Circuits and Biological Systems Group. He is now also a visiting scientist at MIT's Research Laboratory of Electronics.
Tejal Ashwin Desai is Sorensen Family Dean of Engineering at Brown University. Prior to joining Brown, she was the Deborah Cowan Endowed Professor in the Department of Bioengineering and Therapeutic Sciences at University of California, San Francisco, Director of the Health Innovations via Engineering Initiative (HIVE), and head of the Therapeutic Micro and Nanotechnology Laboratory. She was formerly an associate professor at Boston University (2002–06) and an assistant professor at University of Illinois at Chicago (1998–2001). She is a researcher in the area of therapeutic micro and nanotechnology and has authored and edited at least one book on the subject and another on biomaterials.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
Kyriacos A. Athanasiou is a Greek Cypriot-American bioengineer who has contributed significantly to both academic advancements as well as high-technology industries. He is currently a Distinguished Professor at the University of California, Irvine. He joined UCI from the University of California, Davis where he also served as the Chair of the Biomedical Engineering department. Before joining the University of California in 2009, he was the Karl F. Hasselmann Professor at Rice University. He has published hundreds of scientific articles detailing structure-function relationships and tissue engineering approaches for articular cartilage, the knee meniscus, and the temporomandibular joint.
A cyborg —a portmanteau of cybernetic and organism—is a being with both organic and biomechatronic body parts. The term was coined in 1960 by Manfred Clynes and Nathan S. Kline. In contrast to biorobots and androids, the term cyborg applies to a living organism that has restored function or enhanced abilities due to the integration of some artificial component or technology that relies on feedback.
Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.
Van C. Mow is a Chinese-born-American bioengineer, known as one of the earliest researchers in the field of biomechanics.
Albert Folch Folch is a Spanish/Catalan scientist, writer, and artist. He is the son of editor Xavier Folch and sinologist Dolors Folch. He is currently a professor in the Department of Bioengineering at the University of Washington who is known for his research into Microfluidics and BioMEMS as well as his works of scientific art.
Buddy Ratner is an American professor of chemical engineering and bioengineering. He is the director of the Research Center for Biomaterials at the University of Washington. He is also the faculty member for the Program for Technology Commercialization at the University of Washington.
George Alexander Truskey is an American biomedical engineer noted for his research on transport phenomena in biological systems, cardiovascular tissue engineering, and cell adhesion to natural and synthetic surfaces.
Thorsten Walles is a German general thoracic surgeon and professor at the University Hospital of Würzburg. He is known for his works in the field of trachea surgery and his research for early diagnosis of lung cancer.
Nancy Allbritton is a Professor of Bioengineering and the Frank & Julie Jungers Dean of the College of Engineering at the University of Washington. She was previously a Kenan Professor and Chair in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University.
Ada Poon is a professor of electrical engineering at Stanford University. She is the principal investigator of Stanford Integrated Biomedical Systems Lab.
Jerome Schultz is an American bioengineering researcher, professor, and university administrator. He is a fellow of several national scientific societies and a member of the National Academy of Engineering. He has held professorships at the University of Michigan, the University of Pittsburgh, University of California, Riverside, and he is currently a Distinguished Professor of Biomedical Engineering at the University of Houston.
Aaron Michael Streets is an African American bioengineer and associate professor in the Department of Engineering at the University of California, Berkeley in Berkeley, California. He is the principal investigator at the Streets Lab, where he and his team use tools from mathematics, physics, and engineering to study biology. Streets is currently developing microfluidic technology for single-cell measurements due to its high-resolution imaging.